biOasis Technologies Ord Shs BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

GREY:BIOAF - Post by User

biOasis Technologies Ord Shs > Sometimes it's just timing:

<< Previous

Bullboard Posts

Next >>

Comment by Boomskidon May 05, 2023 3:24pm

104 Views

Post# 35433669

RE:Sometimes it's just timing:

Here's a question for you, poof.

Since Mark Day left Bioasis, has Bioasis communicated with anybody on its scientific advisory board? (other than Saltarelli, who still appears to be on that board despite being on that other board)

jd

<< Previous

Bullboard Posts

Next >>

Three micro-cap stocks on an upswing worth riding